Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04544436
Brief Title: A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)

First Submitted : September 4, 2020
First Submitted that Met QC Criteria : September 4, 2020
First Posted : September 10, 2020

Last Update Submitted that Met QC Criteria : February 9, 2021
Last Update Posted : February 10, 2021